{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:12:53Z","timestamp":1789423973997,"version":"build-2803163510"},"publisher-location":"Chichester, UK","reference-count":106,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001689.pub2","type":"reference-entry","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T16:24:11Z","timestamp":1273595051000},"source":"Crossref","is-referenced-by-count":27,"title":["Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period"],"prefix":"10.1002","author":[{"given":"Rebecca","family":"Tooher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Dowswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy-Jane","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,12]]},"reference":[{"key":"10.1002\/14651858.CD001689.pub2-BIB1|cit1","first-page":"835","article-title":"A randomised, double blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thromboembolic events after caesarean section: a pilot study","volume":"108","author":"Burrows","year":"2001","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB4|cit2","unstructured":"Casele H Thrombosis prophylaxis in pregnancy www.enh.org"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD001689.pub2-BIB2|cit3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ajog.2005.10.036","article-title":"Bone density changes in women receiving thromboprophylaxis in pregnancy [abstract]","volume":"193","author":"Casele","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB3|cit4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ajog.2006.06.080","article-title":"Bone density changes in women who receive thromboprophylaxis in pregnancy","volume":"195","author":"Casele","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02637189","article-title":"A randomised trial to compare the effect of pre- or postoperative nandroparin on blood loss during elective caesarean section","volume":"17","author":"Cornette","year":"2002","journal-title":"Phlebology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1055\/s-0037-1616738","article-title":"Thromboprophylaxis following caesarean section. A comparison of the antithrombotic properties of three low molecular weight heparins - dalteparin, enoxaparin and tinzaparin","volume":"86","author":"Ellison","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB7|cit7","first-page":"94","article-title":"Comparisons of the anti-factor XA activities of three commonly used low molecular weight heparins following caesarean section","volume":"45","author":"Ellison","year":"2000","journal-title":"Scottish Medical Journal"},{"key":"10.1002\/14651858.CD001689.pub2-BIB8|cit8","first-page":"823","article-title":"Thromboprophylaxis following caesarean section: comparison of the anti-factor Xa activities of dalteparin, enoxaparin and tinzaparin","volume":"107","author":"Ellison","year":"2000","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001689.pub2-BIB9|cit9","first-page":"S52","article-title":"Randomised controlled trial (PEACH) and meta-analysis of thromboprophylaxis using low-molecular weight heparin (enoxaparin) after caesarean section","volume":"22","author":"Brocklehurst","year":"2002","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB10|cit10","first-page":"53","article-title":"Thromboprophylaxis in pregnancy trials: apple, plum and peach","volume":"105 Suppl 17","author":"Brocklehurst","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low molecular weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB12|cit12","unstructured":"National Perinatal Epidemiology Unit The PEACH Study www.npeu.ox.ac.uk\/trials\/peach.html"},{"key":"10.1002\/14651858.CD001689.pub2-BIB13|cit13","first-page":"53","article-title":"Thromboprophylaxis in pregnancy trials: apple, plum and peach","volume":"105 Suppl 17","author":"Brocklehurst","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low molecular weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001689.pub2-BIB15|cit15","first-page":"S44","article-title":"Antenatal thromboprophylaxis using low molecular weight heparin (enoxaparin) for women at risk of thromboembolic disease: multicentre placebo controlled randomised trial (APPLE) and systematic review","volume":"22","author":"Gates","year":"2002","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB16|cit16","unstructured":"National Perinatal Epidemiology Unit The APPLE Study www.npeu.ox.ac.uk\/trials\/apple.html"},{"key":"10.1002\/14651858.CD001689.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1471-0528.1998.tb10212.x","article-title":"Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin","volume":"105","author":"Gibson","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB18|cit18","first-page":"314","article-title":"Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women","volume":"23","author":"Harenberg","year":"1993","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub2-BIB19|cit19","first-page":"10","article-title":"Perioperative thrombosis prophylaxis at the time of caesarean section: results of a randomised prospective comparative study with 6% hydroxyethyl starch 0.62 and low dose heparin","volume":"195","author":"Heilman","year":"1991","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"key":"10.1002\/14651858.CD001689.pub2-BIB20|cit20","first-page":"211","article-title":"The rheological changes after cesarean section: the influence of low molecular weight or unfractionated heparin on the rheological properties of blood","volume":"37","author":"Heilmann","year":"2007","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1002\/14651858.CD001689.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/bmj.296.6635.1505-a","article-title":"Effect of low dose heparin on blood loss at caesarean section","volume":"296","author":"Hill","year":"1988","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001689.pub2-BIB22|cit22","series-title":"12th FIGO World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil","article-title":"The effect of low dose heparin on blood loss at caesarean section","author":"Hill","year":"1988"},{"key":"10.1002\/14651858.CD001689.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-0528.1983.tb06458.x","article-title":"The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial","volume":"90","author":"Howell","year":"1983","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB24|cit24","first-page":"120","article-title":"Use of LMW heparin (Fragmin) for the prevention of thromboembolism in obstetrics","volume":"198","author":"Krauss","year":"1994","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"key":"10.1002\/14651858.CD001689.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0049-3848(99)00110-3","article-title":"Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy","volume":"96","author":"Pettila","year":"1999","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin","volume":"87","author":"Pettila","year":"2002","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0028-2243(75)90036-2","article-title":"Prevention of postpartum venous thrombosis with low doses of heparin","volume":"5","author":"Segal","year":"1975","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub2-BIB28|cit28","first-page":"925","article-title":"Prevention of thromboembolism by physiotherapy with and without low dose heparin in gynecology and obstetrics. Results of a controlled, randomized multicenter study","volume":"101","author":"Welti","year":"1981","journal-title":"Revue Medicale de la Suisse Romande"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/01443610802042688","article-title":"Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology","volume":"28","author":"Badawy","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001721-199806000-00006","article-title":"A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagulation and Fibrinolysis"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the live-enox study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertility & Sterility"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD001689.pub2-BIB35|cit32","first-page":"702a","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss. The LIVE-ENOX study [abstract]","volume":"100","author":"Brenner","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub2-BIB32|cit33","first-page":"16a","article-title":"Enoxaparin treatment improves the gestational outcome of pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study [abstract]","volume":"102","author":"Brenner","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub2-BIB33|cit34","first-page":"OC084","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study [abstract]","volume":"1","author":"Brenner","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub2-BIB34|cit35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub2-BIB36|cit36","first-page":"146","article-title":"Recurrent fetal loss: prospective evaluation of the efficacy of three different thromboprophylaxis regimens: aspirin versus low molecular weight heparin versus low molecular weight heparin plus aspirin [abstract]","volume":"91","author":"Chistolini","year":"2006","journal-title":"Hematology Journal"},{"key":"10.1002\/14651858.CD001689.pub2-BIB37|cit37","unstructured":"De Vries JIP Low molecular weight heparin (Fragmin (R)) in pregnant women with a history of uteroplacental insufficiency and thombophilia, a randomized trial (FRUIT-study) Netherlands Trial Register (http:\/\/www.trialregister.nl)"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB38|cit38","first-page":"143","article-title":"Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss","volume":"34","author":"Dendrinos","year":"2007","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","article-title":"A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin","volume":"35","author":"Kutteh","year":"1996","journal-title":"American Journal of Reproductive Immunology"},{"issue":"5","key":"10.1002\/14651858.CD001689.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB42|cit42","unstructured":"Middeldorp S Aspirin and\/or low molecular weight heparin for women with unexplained recurrent miscarriage and\/or intra-uterine fetal death Netherlands Trial Register (http:\/\/www.trialregister.nl)"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD001689.pub2-BIB44|cit44","first-page":"44","article-title":"Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome","volume":"147 Suppl 1","author":"Cohen","year":"1996","journal-title":"Annales de Medicine Interne"},{"key":"10.1002\/14651858.CD001689.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD001689.pub2-BIB47|cit46","first-page":"S46","article-title":"Dalteparin in prevention of recurrence of severe obstetrical complications in women without thrombophilia","volume":"29","author":"Rey","year":"2007","journal-title":"JOGC: Journal of Obstetrics and Gynaecology Canada"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub2-BIB46|cit47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"8","key":"10.1002\/14651858.CD001689.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (aps) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"Journal of Obstetrics & Gynaecology Canada: JOGC"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD001689.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ajog.2004.09.049","article-title":"Efficacy of enoxaparin for improving pregnancy outcomes and uteroplacental blood flow in women with thrombophilia and recurrent pregnancy loss [abstract]","volume":"191","author":"Thaler","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD001689.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect of prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD001689.pub2-BIB51|cit51","first-page":"S182","article-title":"Dalteparin versus unfractionated heparin for prophylactic anticoagulation during pregnancy [abstract]","volume":"185","author":"Veciana","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB52|cit52","first-page":"A40","article-title":"Prevention of deep vein thrombosis (DVT) in pregnancy, after caesarean section and after gynaecological abdominal surgery. A comparison between low molecular weight heparin (LMW) and standard heparin (UFH) [abstract]","volume":"62 Suppl 1","author":"Dittmer","year":"1991","journal-title":"Annals of Haematology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD001689.pub2-BIB53|cit53","first-page":"S66","article-title":"Low molecular weight heparin is associated with less peripartum blood loss than unfractionated heparin [abstract]","volume":"178","author":"Hamersley","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1055\/s-0028-1088777","article-title":"Therapy with dalteparin for habitual abortion - presentation of the ETHiG II-Studie","volume":"68","author":"Kamin","year":"2008","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"10.1002\/14651858.CD001689.pub2-BIB55|cit55","unstructured":"Rodger M The STOP CLOT pilot study: study of low molecular weight heparin in high risk postpartum women following cesarean section (ongoing trial) ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"key":"10.1002\/14651858.CD001689.pub2-BIB56|cit56","unstructured":"Rodgers M Thrombophilia in pregnancy prophylaxis study (TIPPS) Ottawa Health Research Institute (http:\/\/www.ohri.ca)"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1160\/TH06-10-0574","article-title":"The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial","volume":"98","author":"Abou-Nassar","year":"2007","journal-title":"Thrombosis and Haemostasis"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD001689.pub2-BIB58|cit58","first-page":"262","article-title":"The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomised trial","volume":"108","author":"Abou-Nassar","year":"2006","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001689.pub2-BIB59|cit59","first-page":"8","article-title":"Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD) [abstract]","volume":"25","author":"Rodger","year":"2006","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001689.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","article-title":"Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial","volume":"5","author":"Rodger","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD001689.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"Abstract No 548","DOI":"10.1182\/blood.V106.11.548.548","article-title":"Prophylactic low molecular weight heparin (LMWH) during pregnancy is not associated with a decrease in bone mineral density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD substudy","volume":"106","author":"Rodger","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0301-2115(01)00496-1","article-title":"How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review","volume":"101","author":"Alfirevic","year":"2002","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB63|cit63","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003747.pub2","article-title":"Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)","author":"Alikhan","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/j.1600-0412.1998.770207.x","article-title":"The cumulative incidence of venous thromboembolism during pregnancy and puerperium - an 11 year Danish population - based study of 63,300 pregnancies","volume":"77","author":"Andersen","year":"1998","journal-title":"Acta Obstetricia et Gynecologia Scandinavica"},{"key":"10.1002\/14651858.CD001689.pub2-BIB65|cit65","first-page":"1055","article-title":"Maternal morbidity in the United States 1979-1986","volume":"76","author":"Atrash","year":"1990","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0889-8545(05)70319-3","article-title":"Current concepts of anticoagulant therapy in pregnancy","volume":"24","author":"Barbour","year":"1997","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD001689.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1046\/j.1538-7836.2003.00504.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--Yes","volume":"1","author":"Brenner","year":"2003","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001689.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies of AT III, Protein C or Protein S: study of 78 women","volume":"63","author":"Conard","year":"1990","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.SMJ.0000051280.53683.B6","article-title":"Thromboembolism prophylaxis and cesarean section: a survey of general obstetricians","volume":"96","author":"Connolly","year":"2003","journal-title":"Southern Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijgo.2005.05.003","article-title":"Management of pregnant women with increased risk of venous thrombosis","volume":"90","author":"Dargaud","year":"2005","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD001689.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","article-title":"The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis","volume":"135","author":"Stefano","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB74|cit74","article-title":"Why mothers die","volume-title":"Report of the Confidential Enquiries into Maternal Deaths 1994-1996","year":"1998"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub2-BIB75|cit75","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002859.pub2","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","article-title":"Frequency of pregnancy-related venous thromboembolism in anticoagulant factor deficient women: implications for prophylaxis","volume":"125","author":"Friederich","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001689.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0029-7844(99)00426-3","article-title":"Incidence, clinical characteristics and timing of objectively diagnosed venous thromboembolism during pregnancy","volume":"94","author":"Gherman","year":"1999","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy","volume":"68","author":"Hall","year":"1980","journal-title":"American Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001689.pub2-BIB80|cit80","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD001689.pub2-BIB81|cit81","first-page":"240","article-title":"Maternal mortality in Sweden, 1980-1988","volume":"84","author":"H\u00f6gberg","year":"1994","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub2-BIB82|cit82","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004734.pub3","article-title":"Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome","author":"Kaandorp","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub2-BIB83|cit83","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005258.pub2","article-title":"Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients","author":"Kakkos","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub2-BIB84|cit84","article-title":"Antiplatelet agents for preventing and treating pre-eclampsia","author":"Knight","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1447-0756.2007.00550.x","article-title":"Single inherited thrombophilias and adverse pregnancy outcomes","volume":"33","author":"Larciprete","year":"2007","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD001689.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0950-3552(97)80026-0","article-title":"Peripartum prophylaxis of thrombo-embolism","volume":"11","author":"Letsky","year":"1997","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB87|cit87","volume-title":"Why mothers die, 2000-2002. The Sixth Report of Confidential Enquiries into Maternal Deaths in the United Kingdom","author":"Lewis","year":"2004"},{"key":"10.1002\/14651858.CD001689.pub2-BIB88|cit88","first-page":"348","article-title":"Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy","volume":"93","author":"Lindhagen","year":"1986","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0029-7844(99)00308-7","article-title":"Thrombotic risk during pregnancy: a population study","volume":"94","author":"Lindqvist","year":"1999","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/003693309604100305","article-title":"Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience","volume":"41","author":"Macklon","year":"1996","journal-title":"Scottish Medical Journal"},{"issue":"10","key":"10.1002\/14651858.CD001689.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1046\/j.1538-7836.2003.00503.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--No","volume":"1","author":"Middeldorp","year":"2003","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD001689.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0950-3552(97)80024-7","article-title":"Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis","volume":"11","author":"Nelson-Piercy","year":"1997","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001689.pub2-BIB93|cit93","volume-title":"Caesarean section","year":"2004"},{"issue":"6076","key":"10.1002\/14651858.CD001689.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/bmj.1.6076.1564","article-title":"May mothers given warfarin breast-feed their infants?","volume":"1","author":"Orme","year":"1977","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001689.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0310057X8701500208","article-title":"A prospective study of dextran-induced anaphylactoid reactions in 5745 patients","volume":"15","author":"Paull","year":"1987","journal-title":"Anaesthesia and Intensive Care"},{"key":"10.1002\/14651858.CD001689.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub2-BIB98|cit98","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005259.pub3","article-title":"Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy","author":"Ramos","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001689.pub2-BIB99|cit99","unstructured":"Royal College of Obstetricians and Gynaecologists Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No. 37 London RCOG"},{"key":"10.1002\/14651858.CD001689.pub2-BIB100|cit100","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD001689.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0002-9378(91)90879-V","article-title":"Thromboembolic disease associated with pregnancy: an 11 year review","volume":"164","author":"Rutherford","year":"1991","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub2-BIB102|cit102","first-page":"56","article-title":"Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database","volume":"108","author":"Simpson","year":"2001","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"896","key":"10.1002\/14651858.CD001689.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/pmj.76.896.354","article-title":"Use of a computerised maternity information system to improve clinical effectiveness: thromboprophylaxis at caesarean section","volume":"76","author":"Taylor","year":"2000","journal-title":"Postgraduate Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD001689.pub2-BIB104|cit104","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006681.pub2","article-title":"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization","author":"Testroote","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001689.pub2-BIB105|cit105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003580","article-title":"Heparin for pregnant women with acquired or inherited thrombophilias","author":"Walker","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001689.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2005.05715.x","article-title":"Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis","volume":"131","author":"Wu","year":"2005","journal-title":"British Journal of Haematology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001689.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001689.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:04:22Z","timestamp":1628528662000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001689.pub2"}},"subtitle":[],"editor":[{"given":"Rebecca","family":"Tooher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,5,12]]},"references-count":106,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001689.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001689.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2010,5,12]]}}}